The institutional review board approved the chemotherapy and MIBG imaging protocols and informed written consent was obtained from all patients. All data were collected in an Excel database and analyzed by SPSS 18.0. 1. However, when FDA is unavailable, DOPA-PET or MIBG scintigraphy can be used as valid alternatives[None]. CT and MR imaging are excellent for detecting mass lesions and for following their size during therapy. 